1,8-naphthalimide imidazo[4,5,1-de]acridones with anti-tumor...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/06 (2006.01) A61K 31/437 (2006.01) A61K 31/4745 (2006.01) A61K 31/496 (2006.01) A61K 31/506 (2006.01) A61P 35/00 (2006.01) C07D 221/00 (2006.01) C07D 235/00 (2006.01)

Patent

CA 2402446

The invention provides imidazoacridone compounds of general formula (1) which have cytotoxic and anti-tumor activity. The invention also provides methods of preparing the compounds, and methods of using the compounds for the treatment of cancer or other mammalian diseases characterized by undesirably high levels of cell proliferation. The compounds of the invention are also expected to have utility as research tools.

L'invention concerne des composés d'imidazoacridone correspondant à la formule générale (1) et possédant une activité cytotoxique et antitumorale. L'invention concerne également des méthodes de préparation desdits composés, ainsi que des méthodes d'utilisation correspondantes dans le traitement du cancer ou d'autres maladies des mammifères caractérisées par une prolifération cellulaire excessive. Les composés de l'invention peuvent s'utiliser également en tant qu'outils pour la recherche.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

1,8-naphthalimide imidazo[4,5,1-de]acridones with anti-tumor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,8-naphthalimide imidazo[4,5,1-de]acridones with anti-tumor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,8-naphthalimide imidazo[4,5,1-de]acridones with anti-tumor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2007233

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.